There is a newer version of the record available.

Published August 23, 2026 | Version 2.0.7

NeuroMetBench v2.0.7: Reproducibility and Provenance Package

Authors/Creators

  • 1. Independent Researcher, Amman, Jordan

Description

NeuroMetBench is a patient-aware benchmarking and claim-admissibility case study for evaluating interpretation limits of transcript-derived metabolic representations in glioma.

Version 2.0.7 is a corrective synchronization and reproducibility release accompanying the manuscript NeuroMetBench: Patient-aware benchmarking reveals interpretation limits of transcript-derived metabolic representations in glioma.

The validated scientific conclusions, biological endpoints, cohorts, thresholds, canonical intervals, statistical results, adverse findings, and interpretation ceilings are unchanged.

Version 2.0.7 corrects repository-publication synchronization defects and other reproducibility metadata identified during the final pre-submission audit. These corrections include synchronization of repository version metadata, citation and Zenodo metadata, release notes and licensing records; correction of the exact supported-domain moderate-effect simulation value to 0.48705882352941177 = 6210/12750; correction of reviewer-facing spatial terminology to 8/12 genes covered; narrowing of CNS wording to a development-disjoint external-case association without implying institution, platform, acquisition-ecosystem, or upstream-processing independence; strengthened claim-evidence traceability; and exact submission-to-reproducibility package identity verification.

The release preserves adverse and non-admitted findings rather than converting them into positive evidence. Broad simulation calibration was not earned, the spatial branch remains structurally non-admitted, the serine aggregate does not outperform the strongest constituent gene, and METAFlux numerical evidence is restricted to the documented primal-feasibility compatibility boundary.

The frozen reproducibility archive has passed repeated 20-check verification, deterministic double-build comparison, three fresh-extraction stranger reproductions, interruption-safety testing, nested checksum and manifest verification, and independent statistical recomputation.

Raw third-party molecular matrices are not redistributed. Complete contemporary raw-to-final execution remains conditional on external source availability, historical environments and dependencies, and applicable third-party licenses.

Reproducibility archive SHA-256:
955bfafae9bf2a3b85f06a0485f27760e23ab72c669ffedf061b736c90670bba

Exact archive size:
21,785,165 bytes

Notes

Version 2.0.7 is a corrective synchronization and reproducibility release.

The validated scientific conclusions, cohorts, endpoints, thresholds, statistical results, canonical intervals, adverse findings, and interpretation ceilings are unchanged from the frozen scientific state.

This version corrects publication and reproducibility metadata identified during the final pre-submission audit, including:

synchronization of GitHub repository version metadata, citation metadata, Zenodo metadata, changelog, release notes, licensing records, VERSION, and checksum records;
correction of the exact supported-domain moderate-effect simulation value to 0.48705882352941177 = 6210/12750;
correction of reviewer-facing spatial terminology to 8/12 genes covered, corresponding to coverage 0.667, below the frozen 0.80 admission threshold;
narrowing of CNS wording from broad “generalization” language to a development-disjoint external-case association/reproduction, without implying independence of institution, platform, acquisition ecosystem, or upstream processing;
strengthened claim-evidence traceability and cross-package identity verification;
deterministic double-build verification;
repeated fresh-extraction stranger reproduction;
interruption-safety testing;
independent statistical recomputation;
public-package hygiene preserving historical identities and adverse statuses while excluding development-only workflow residue.

No adverse, null, unsupported, contradictory, or non-admitted result was removed or converted into positive evidence.

Important interpretation boundaries remain in force:

RNA-protein concordance is not direct measurement of metabolic flux;
the three-gene serine aggregate does not outperform the strongest constituent gene;
broad simulation calibration was not earned;
the spatial branch remains structurally non-admitted;
METAFlux numerical evidence is limited to the documented primal-feasibility compatibility assessment;
the CNS cohort is patient-disjoint but should not be described as institution-, platform-, or ecosystem-independent validation;
the study is a retrospective case study and does not establish prospective clinical utility or general validation of transcript-derived metabolic inference.

The reproducibility archive passed the complete 20/20 verification suite, deterministic A/B build identity, three independent fresh-extraction stranger runs, nested manifest verification, interruption-safety testing, and independent recomputation of the principal statistical authorities.

Raw third-party molecular matrices are not redistributed. Contemporary raw-to-final reproduction remains conditional on source availability, historical software environments and dependencies, and applicable external data-use and licensing terms.

Frozen reproducibility archive

Filename: NeuroMetBench_v2.0.7_reproducibility_release.zip

SHA-256: 955bfafae9bf2a3b85f06a0485f27760e23ab72c669ffedf061b736c90670bba

Size: 21,785,165 bytes

Historical releases remain immutable and are preserved as part of the project provenance record.

Files

NeuroMetBench_v2.0.7_reproducibility_release (1).zip

Files (21.8 MB)

Name Size
md5:a3ec6608a4502815c4473fa9c4587afd
21.8 MB Preview Download

Additional details

Related works

Is supplement to
Software: https://github.com/build33Mercury/NeuroMetBench (URL)